PIK3CA-related overgrowth spectrum (PROS) is a group of rare genetic conditions that cause parts of the body to grow too much or in unusual ways, and managing symptoms effectively is a journey that involves understanding various treatment approaches available today.

Managing a Complex Condition: Understanding Treatment Goals

When someone receives a diagnosis of PIK3CA-related overgrowth spectrum, the focus shifts immediately to managing symptoms and improving daily life. PROS is not a single disease but rather a collection of related conditions—all caused by changes in a gene called PIK3CA—that can affect many different parts of the body. Because the symptoms vary so widely from person to person, treatment plans need to be carefully tailored to each individual’s specific needs.^[1]

The main goals of treatment are to control symptoms, prevent complications, and help people with PROS live as comfortably and independently as possible. This might mean reducing pain, improving movement, managing seizures, or addressing problems with blood vessels or organs. Treatment decisions depend on many factors, including which parts of the body are affected, how severe the symptoms are, the person’s age, and how the condition changes over time.^[1]

Medical societies and healthcare teams follow established guidelines for treating PROS conditions, which include a combination of standard therapies that have been used for years. At the same time, researchers continue to explore new treatments through clinical trials, searching for ways to address the root cause of these conditions rather than just managing the symptoms that arise from them.^[6]

Standard Treatment Approaches: Addressing Symptoms as They Arise

Most people with PROS will need multiple types of treatment throughout their lives because the condition can affect so many different body systems. The standard approach to care typically involves treating each symptom or complication individually, using methods that have been proven effective through years of medical practice.^[11]

Surgery is one of the most commonly used treatments for PROS. When overgrowth of tissue causes problems with movement, appearance, or organ function, surgical removal of the excess tissue may be necessary. This is particularly common when overgrowth affects the limbs, making it difficult to walk or use the hands. For example, if one leg grows significantly longer than the other, surgery can help correct the length difference. However, because the genetic mutation that causes PROS remains in the body’s cells, tissue can continue to grow back over time, and people may need multiple surgeries throughout their lives.^[9]

For children with brain overgrowth who experience seizures, antiseizure medications (also called anticonvulsants) are often prescribed. These drugs work by calming overactive nerve signals in the brain. Common medications in this category help prevent the electrical storms in the brain that cause seizures. The effectiveness of these medications depends largely on whether only a small part of the brain is affected or whether the overgrowth is more widespread. In cases where medications don’t adequately control seizures, brain surgery may be considered.^[9]

When PROS affects blood vessels, creating vascular malformations (abnormal tangles or clusters of veins, arteries, or capillaries), several treatment options exist. Sclerotherapy is a procedure where doctors inject a special medication directly into the abnormal blood vessels, causing them to shrink and eventually close off. This can help reduce swelling, pain, and the risk of bleeding. Some people may also need blood-thinning medications, called anticoagulants, to prevent dangerous blood clots from forming in abnormal veins.^[5][10]

For skin lesions called epidermal nevi (patches of thickened or discolored skin), treatment options include topical creams containing steroids or other anti-inflammatory ingredients. When lesions are painful, itchy, or cosmetically concerning, laser treatment can help reduce their appearance. In some cases, surgical removal may be the best option for getting rid of them completely.^[9]

Many children with PROS face feeding difficulties, particularly if they have poor muscle tone or structural problems affecting swallowing. A nutritionist or feeding specialist can create individualized eating plans to ensure proper nutrition. In severe cases, a feeding tube may be necessary temporarily or long-term to provide adequate calories and nutrients for growth and development.^[12]

Endocrine problems, though less common, require specific medications when they occur. Some individuals develop low blood sugar (hypoglycemia), an underactive thyroid gland (hypothyroidism), or growth hormone deficiency. Each of these conditions is treated with hormone replacement therapy or medications that help regulate blood sugar levels.^[1]

Physical therapy, occupational therapy, and speech therapy play crucial roles in helping people with PROS maintain or improve their function. Physical therapists work on movement, strength, and balance, which can be challenging when limbs are different sizes or joints are unstable. Occupational therapists help people adapt their daily activities and may recommend assistive devices such as special grips for writing, adaptive clothing, or modified tools for eating and personal care. Speech therapists assist with communication difficulties and swallowing problems that can occur when PROS affects the face, mouth, or brain.^[10]

The duration of treatment varies tremendously. Some therapies, like physical therapy, may continue for years or throughout a person’s lifetime. Medications for seizures or hormone problems typically need to be taken daily on an ongoing basis. Surgical interventions are performed as needed when symptoms worsen or new problems develop.^[11]

Side effects from treatments can occur. Surgery carries risks of bleeding, infection, and complications from anesthesia. Antiseizure medications may cause drowsiness, dizziness, weight gain, or mood changes. Sclerotherapy can cause temporary pain, swelling, or skin discoloration at the injection site. Blood thinners increase the risk of bleeding and bruising. Each treatment decision requires weighing these potential risks against the expected benefits for that individual.^[11]

Breaking New Ground: Treatment in Clinical Trials

While standard treatments help manage symptoms, they don’t address the underlying cause of PROS: overactive PIK3CA genes that tell cells to grow and divide too much. This is where clinical trials come in. Researchers have been testing a promising new class of drugs called PIK3CA inhibitors, which are designed to block the faulty protein produced by the mutated gene.^[5]

The most extensively studied drug in this category is alpelisib (also known by the code name BYL719). This medication represents a fundamentally different approach to treating PROS because it targets the molecular pathway that causes tissue overgrowth, rather than just treating the symptoms that result from it. Alpelisib works by blocking the hyperactive PI3K enzyme, which reduces excessive cell signaling and helps regulate cell growth and division back toward normal levels.^[6][15]

Clinical trials testing alpelisib have shown encouraging results. In a significant study published in the journal Nature, researchers treated patients with severe PROS using alpelisib and observed improvements in several important measures. Many patients experienced a reduction in pain and a decrease in the size of their overgrown tissues and vascular malformations. These improvements helped some people move more easily, reduced their need for other treatments, and generally improved their quality of life.^[5]

Based on these promising results, the United States Food and Drug Administration (FDA) approved alpelisib in 2022 specifically for adults and children with severe PROS who require systemic (whole-body) therapy. This approval marked a major milestone because it was the first medication approved to treat the underlying cause of PROS rather than just managing individual symptoms.^[15]

Clinical trials for PROS treatments typically follow the standard phases of drug testing. Phase I trials focus primarily on safety—researchers carefully monitor participants to determine what doses can be given safely and what side effects might occur. Phase II trials look at whether the drug actually works to improve symptoms or reduce overgrowth, and researchers continue to monitor safety. Phase III trials compare the new treatment with standard care (or placebo when ethically appropriate) in larger groups of people to confirm effectiveness and watch for less common side effects.^[6]

The mechanism of action for PIK3CA inhibitors like alpelisib is quite specific. The PIK3CA gene normally provides instructions for making a protein called p110α, which is part of a larger enzyme complex called phosphoinositide 3-kinase (PI3K). This enzyme acts like a switch that controls important cell functions including growth, division, movement, and survival. In PROS, mutations cause the switch to stay stuck in the “on” position, leading to uncontrolled cell growth. Alpelisib essentially turns down the volume on this overactive switch, helping to restore more normal cell behavior.^[5]

Not everyone with PROS is eligible for treatment with PIK3CA inhibitors. These medications are typically reserved for people with severe symptoms that significantly impact their health and quality of life, particularly when standard treatments haven’t been effective enough. Doctors consider factors such as the extent of tissue overgrowth, how rapidly the condition is progressing, the presence of complications affecting vital organs, and whether surgeries or other treatments have failed to provide adequate relief.^[15]

Clinical trials for PROS treatments have been conducted in multiple countries including the United States, various European nations, and other locations worldwide. Patient eligibility depends on several factors: the specific type of PROS diagnosis, genetic confirmation of a PIK3CA mutation, severity of symptoms, age (some trials include only adults while others include children), and overall health status. Because PROS is rare, researchers actively seek eligible participants for ongoing studies.^[6]

Like all medications, PIK3CA inhibitors can cause side effects. In clinical trials, some common side effects observed with alpelisib included high blood sugar levels (which sometimes required treatment with diabetes medications), mouth sores, diarrhea, nausea, rash, and fatigue. More serious side effects can include significant increases in blood sugar, severe rash, or kidney problems. Because of these potential side effects, people taking PIK3CA inhibitors need regular monitoring with blood tests and checkups to catch and manage any problems early.^[10]

Other PIK3CA inhibitors and innovative therapies continue to be explored in early-stage research. Scientists are investigating whether other drugs that affect the same cellular pathways might be effective, whether combination therapies might work better than single drugs, and whether there are ways to deliver these medications more directly to affected tissues to reduce side effects.^[10]

Some researchers have also explored whether anti-inflammatory medications like aspirin might help reduce PROS symptoms. Early research suggests that medicines that reduce inflammation could potentially slow tissue overgrowth, though much more study is needed to understand whether this approach is truly beneficial.^[9]

Most common treatment methods

• Surgical interventions
  • Removal of overgrown tissue from limbs, trunk, or face to improve movement and function
  • Correction of bone abnormalities and unequal limb lengths
  • Brain surgery for severe seizures or to relieve pressure from brain overgrowth
  • Laser treatment for skin lesions and vascular malformations
  • Multiple surgeries may be needed over time as tissue can regrow
• Medications for symptom management
  • Antiseizure medications (anticonvulsants) to control seizures in people with brain involvement
  • Blood thinners (anticoagulants) to prevent blood clots in abnormal blood vessels
  • Hormone replacement for thyroid problems and growth hormone deficiency
  • Medications to manage low blood sugar (hypoglycemia)
  • Topical creams with steroids or antihistamines for skin lesions
  • Pain relief medications including anti-inflammatory drugs
• Sclerotherapy for vascular malformations
  • Injection of medication directly into abnormal blood vessels
  • Causes vessels to shrink and close off
  • Helps reduce swelling, pain, and bleeding risk
  • May need to be repeated multiple times
• Targeted molecular therapy
  • PIK3CA inhibitors like alpelisib (BYL719) block the overactive enzyme causing overgrowth
  • FDA-approved for severe PROS requiring systemic therapy
  • First treatment to address the underlying genetic cause rather than just symptoms
  • Requires regular monitoring for side effects including high blood sugar
• Rehabilitation therapies
  • Physical therapy to improve movement, strength, and balance
  • Occupational therapy to adapt daily activities and recommend assistive devices
  • Speech therapy for communication and swallowing difficulties
  • May continue throughout life as needs change
• Nutritional support
  • Individualized eating plans created by nutritionists
  • Feeding therapy for children with swallowing difficulties
  • Feeding tubes when necessary to ensure adequate nutrition
  • Monitoring of weight and growth parameters

Living with PROS: Daily Life Considerations

Beyond medical treatments, people with PROS often need various types of support to navigate daily life. The impact of the condition varies greatly depending on which body parts are affected and how severely. Some individuals have relatively mild symptoms that cause minor inconveniences, while others face significant challenges that affect mobility, learning, and independence.^[12]

Many babies and young children with PROS have poor muscle tone, which can make it harder for them to sit up, crawl, and walk on schedule. They may also struggle with eating and swallowing. Early intervention services, including physical therapy starting in infancy, can help children reach developmental milestones and build strength. Some children catch up over time, while others continue to need ongoing support.^[12]

Mobility challenges are common when PROS affects the legs, feet, or spine. Walking may be difficult if legs are different lengths, feet are unusually large or wide, or joints are unstable. Many people benefit from mobility aids such as canes, walkers, braces, splints, or wheelchairs. Shoe lifts can help even out leg length differences. Finding shoes that fit properly can be challenging when feet are affected, and some people need custom-made footwear or prefer to go barefoot or wear only socks at home.^[12]

At school, children with PROS may need special accommodations. Those with intellectual or developmental delays, speech impairments, or hearing problems may benefit from special education services. In the United States, families can work with schools to create an Individualized Education Plan (IEP) or 504 Plan—legal documents that describe what accommodations the child needs, such as extra time for tests, modified assignments, or the use of assistive technology.^[12]

The psychosocial impact of PROS should not be underestimated. Living with a visible difference or physical limitations can lead to increased stress, anxiety, and depression for both children and adults. Feelings of isolation, frustration about repeated medical procedures, and concerns about the future are common. Mental health support, including counseling or therapy, can be valuable. Support groups where families can connect with others facing similar challenges provide practical advice and emotional support that helps people feel less alone.^[7][13]

Looking Toward the Future: What Lies Ahead

The outlook for people with PROS varies significantly based on individual circumstances. Some people with isolated, mild forms of the condition diagnosed in childhood can live typical life spans and see their symptoms stabilize or even lessen somewhat as they age. However, not all cases follow this pattern, and some people experience progressive worsening of symptoms over time.^[6]

People with brain involvement tend to face more significant long-term challenges. Brain overgrowth can lead to developmental and cognitive delays, ongoing seizures despite medication, and neurological problems. The degree of intellectual disability often relates to the severity of seizures, the presence of abnormal brain structure, and whether fluid buildup in the brain (hydrocephalus) occurs.^[1]

Systemic involvement—when multiple body systems are affected—or complications affecting vital organs can lead to serious health concerns. Cardiovascular complications from vascular malformations, mobility challenges from severe skeletal involvement, or life-threatening problems from organs being pushed or compressed by overgrown tissue all require intensive ongoing medical care.^[6]

The approval of alpelisib and ongoing research into other targeted therapies offer hope that future treatments will be more effective at controlling the progression of PROS. As scientists learn more about exactly how PIK3CA mutations cause different symptoms, they may be able to develop even more precise treatments with fewer side effects. Research continues into better ways to predict who will benefit most from which treatments, potentially allowing for more personalized medicine approaches.^[15]

Because PROS is rare, exact numbers for incidence and prevalence are not well established. Many cases likely go undiagnosed, particularly milder forms, and not all cases receive genetic testing to confirm the PIK3CA mutation. Estimates suggest approximately 14 people per one million have a PROS-related condition, though the true number may be higher.^[7]